NATCO PHARMA LTD

NATCOPHARM NSE
NATCOPHARM
NATCO PHARMA LTD NSE
 
Kommande intäkter
Utdelning per andel
Börsvärde
Utdelning
P/E-tal
Kommande intäkter
Utdelning per andel
Börsvärde
Utdelning
P/E-tal

NATCOPHARM financial statements

NATCO PHARMA LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of NATCOPHARM for the last quarter is 3.77B INR, and it's 8.07% lower compared to the previous quarter. The net income of Q2 21 is 651.00M INR.

TTM
Bruttovinst
Totala intäkter
Cost of goods sold
Operating expenses (excl. COGS)
Rörelseintäkt
Non-operating income, total
Pretax income
Equity in earnings
Taxes
Non-controlling/minority interest
After tax other income/expense
Net income before discontinued operations
Discontinued operations
Nettoinkomst
Dilution adjustment
Preferred dividends
Diluted net income available to common stockholders
Basic earnings per share (Basic EPS)
Diluted earnings per share (Diluted EPS)
Average basic shares outstanding
Diluted shares outstanding
EBITDA
EBIT
Totala rörelsekostnader